Navigation Links
Advanced Life Sciences Announces Third Quarter 2009 Financial Results
Date:11/10/2009

Drugs Advisory Committee meeting that will discuss CAP clinical trial design and endpoints;
  • Work with the FDA and Pfizer (formerly Wyeth) to identify the scope and protocol design for the additional clinical data that would be required to satisfy the FDA's request for additional efficacy information to complete the CAP clinical development program and gain agency approval;
  • Work with the FDA to determine the regulatory package needed for approval in the biodefense indications of anthrax, plague and tularemia;
  • Advance negotiations with prospective U.S. and E.U. partners for the development and commercialization of Restanza.
  • Financial Outlook

    To fund ongoing operations in 2010, the Company intends to raise additional capital through commercial partnerships and/or the sale of equity.

    Conference Call Details

    Advanced Life Sciences will host a conference call and live webcast at 10:00 a.m. Eastern Time on Tuesday, November 10, 2009 to discuss the Company's third quarter financial results.

    The conference call will be webcast simultaneously over the Internet. Please visit the Investor Relations section of the Advanced Life Sciences corporate website www.advancedlifesciences.com. Alternatively, callers may participate in the conference call by dialing 888.713.4214 (domestic) or 617.213.4866 (international). The passcode for the conference call is 75545191. A replay of the conference call will be available until November 17, 2009. Callers may access the telephone replay by dialing 888-286-8010 (domestic) or 617-801-6888 (international), passcode 79025053. Investors are advised to dial into the call at least ten minutes prior to the call to register. Participants may pre-register for the call at https://www.theconferencingservice.com/prereg/key.process?key=PGFUTHTV6. Pre-registrant
    '/>"/>

    SOURCE Advanced Life Sciences Holdings, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. Boston Scientifics Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan
    2. Free 2D/3D Advanced Visualization Software for CT and MRI Now Available From FiatLux Imaging
    3. Varian Medical Systems Selected to Supply Major Project to Bring Advanced Radiotherapy Treatments to North of Portugal
    4. Healthcare Industry Celebrates 25 Years of Advanced Pain Management With PCA Infusion System
    5. Lumenis Introduces Advanced Retinal Laser Delivery Technology at the 2009 American Academy of Ophthalmology Annual Meeting in San Francisco, California, USA
    6. Advanced Health Media Named to Deloittes 2009 Technology Fast 500(TM)
    7. Peregrine Pharmaceuticals Reports 61% Objective Response Rate in 46-Patient Bavituximab Phase II Trial in Advanced Breast Cancer
    8. FDA approves GlaxoSmithKlines VOTRIENT(TM) for advanced renal cell cancer
    9. FDA Approves New Treatment for Advanced Form of Kidney Cancer
    10. Verathon Introduces the GlideScope(R) Cobalt Advanced Video Laryngoscope (AVL); New Digital Technology Facilitates Quick Intubations
    11. New ALS Patient Simulator Advanced Provides Valuable Training for EMS Teams and In-Hospital Emergency Personnel
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/27/2015)... May 27, 2015 ... the addition of the  "2015 Strategies in ... their offering.       (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... strategic overview of the orthopedics market, including ... and product categories. , ,In addition, the ...
    (Date:5/27/2015)... , May 27, 2015 ... has announced the addition of the  "North ... Forecasts (2014 - 2019)"  report to ... ,  , ,Mammography is a detailed type ... system to inspect breasts. A mammography exam, ...
    (Date:5/27/2015)... -- OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts to ... series of diverse complications arising from the presence of ... which cause a rapidly progressing hyperactive host immune response ... depending on disease severity. The syndrome places a major ... marketplace, which for the purposes of this report is ...
    Breaking Medicine Technology:Global Orthopedics Market Strategies 2015 2North America Mammography Market - Growth, Trends And Forecasts (2014 - 2019) 2OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts to 2021 2OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts to 2021 3OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts to 2021 4
    ... SILVER SPRING, Md., May 6, 2011 The U.S. Food ... allow a new group of patients at risk of stroke ... RX Acculink carotid stent. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... neck bring blood to the brain. The blood flow in ...
    ... BEACH, Calif., May 6, 2011 Yesterday, the ... Novartis drug Afinitor® (everolimus) for the treatment of ... less than five percent of all pancreatic cancer ... aggressive than the more common form of pancreatic ...
    Cached Medicine Technology:FDA Expands Approved Use For Carotid Stent 2FDA Expands Approved Use For Carotid Stent 3FDA Approves Novartis Drug Afinitor to Treat Pancreatic Neuroendocrine Tumors 2
    (Date:5/27/2015)... (PRWEB) May 27, 2015 Allred Dental located ... help patients - who need extensive dental treatment - understand ... treatment options customized for their problems. , Dr. Jeff Allred ... visual presentation of the assessment of the patient’s oral health ... which can treat their oral health problems. , “The dental ...
    (Date:5/27/2015)... 27, 2015 Black Book Rankings, ... surveys in the multiple services and software industries, ... the highest ranked Electronic Health and Medical Record ... special research focus on implemented EHR users, Black ... vendors with the highest scores in client experience ...
    (Date:5/27/2015)... (PRWEB) May 27, 2015 The MedSpa ... three FDA-approved dermal filler treatments in Abilene, Texas: Xeomin®, ... reduce the appearance of glabellar lines, better known as ... Belotero Balance® is designed to treat smoker’s lines around ... the chin, while Radiesse® improves the appearance of smile ...
    (Date:5/27/2015)... Mountain View, CA (PRWEB) May 27, 2015 ... Napa Valley will be able to reach for Organic Coconut ... 2015. Coco Libre will be available at VIP areas, artist ... will also be available at area hotels and on festival ... as a partner this year,” said Noa Elan, Director of ...
    (Date:5/27/2015)... Genius Monkey is pleased to announce that ... they have boosted sales for the Utah Honda Dealers ... for seven Utah-based dealers. , Until recently, the ... media. In 2014 the Utah Honda dealers changed their ... Monkey , shifted their marketing campaigns more towards targeted ...
    Breaking Medicine News(10 mins):Health News:San Marcos Dentistry Office Offering a New Service Dental Case Planning 2Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 2Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 3Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 4Health News:The MedSpa at Hendrick Introduces Xeomin®, Belotero Balance® and Radiesse® Injectables 2Health News:Coco Libre Puts Organic Coconut Water on the Line-up at BottleRock Napa 2Health News:Genius Monkey Boosts Utah Honda Dealers Website Traffic 142% 2
    ... 28, 2010 (Geneva, Switzerland) At the UN Millennium ... world leaders gathered to review progress on the eight ... ill-health by 2015. As the summit came to a ... $40bn to reach the goals, with particular emphasis on ...
    ... HealthDay Reporter , TUESDAY, Sept. 28 (HealthDay News) ... can vary among different racial and ethnic groups, which ... the value of cholesterol-lowering drugs, a new British study ... elevated levels have been linked -- but not proven ...
    ... Thompson HealthDay Reporter , TUESDAY, Sept. 28 (HealthDay ... to like about a break in the school day set ... Now fast-forward to your adult life. What if your workplace ... think it,s not only a good idea but possibly one ...
    ... could provide a target to develop new treatments for the ... and The London School of Medicine and Dentistry. Pancreatic cancer ... its lack of symptoms in the early stages, late diagnosis ... research funded by the Pancreatic Cancer Research Fund ...
    ... cats may worsen your ragweed allergies, according to a study ... pet allergies often develop ragweed allergy symptoms more quickly than ... is in full swing, those symptom differences subside. ... the departments of medicine and microbiology & immunology, exposed 123 ...
    ... of scientists from Mayo Clinic, the University of Illinois ... leveraging a long-standing research relationship to apply results from ... predictors for preterm birth. "This is a collaborative ... fundamental problems in maternal-fetal health," says Douglas Creedon, M.D., ...
    Cached Medicine News:Health News:International AIDS Society emphasizes universal access to HIV prevention, treatment and care as a prerequisite for improving maternal and child health 2Health News:International AIDS Society emphasizes universal access to HIV prevention, treatment and care as a prerequisite for improving maternal and child health 3Health News:C-Reactive Protein Levels Vary By Race: Study 2Health News:C-Reactive Protein Levels Vary By Race: Study 3Health News:Adding Recess to the Workday Gains Backers 2Health News:Adding Recess to the Workday Gains Backers 3Health News:Adding Recess to the Workday Gains Backers 4Health News:Protein key to growth of pancreatic cancer 2Health News:Microbiomes may hold key to better understanding of preterm birth 2
    SHIONORIA BNP,is a reagent used in the measurement of blood BNP. The blood BNP test allows accurate estimation of coronary functions....
    The Elisa test is used for the detection and semi-quantitative determination of IgG, antibodies to myeloperoxidase in human sera as an aid to the diagnosis is of microscopic polyangiitis....
    ... of this Enzyme ImmunoAssay (EIA) is as ... immobilised on a 96 well microtiter plate. ... washing, the trapped molecule is covalently linked ... groups. After washing and denaturing treatment, Angiotensin ...
    ... a solid phase two-site enzyme immunoassay. ... sandwich technique in which two monoclonal ... determinants on the insulin molecule. During ... with peroxidase-conjugated anti-insulin antibodies and anti-insulin ...
    Medicine Products: